JD(JD)
JD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.38T | $1.47T | $1.55T | $1.64T |
| Low | $1.36T | $1.44T | $1.46T | $1.55T |
| High | $1.40T | $1.50T | $1.60T | $1.70T |
| EBITDA Avg | $37.58B | $39.89B | $42.03B | $44.64B |
| Low | $36.98B | $39.12B | $39.64B | $42.09B |
| High | $37.95B | $40.74B | $43.37B | $46.06B |
| EBIT Avg | $28.04B | $29.76B | $31.36B | $33.30B |
| Low | $27.59B | $29.19B | $29.57B | $31.41B |
| High | $28.31B | $30.40B | $32.36B | $34.36B |
| Net Income Avg | $33.05B | $41.02B | $51.13B | $54.28B |
| Low | $31.02B | $30.59B | $34.68B | $50.26B |
| High | $35.08B | $51.45B | $67.58B | $56.52B |
| EPS Avg | $22.12 | $28.76 | $35.32 | $36.45 |
| Low | $20.83 | $20.55 | $23.29 | $33.75 |
| High | $23.56 | $34.55 | $45.39 | $37.96 |
| Analysts (Rev / EPS) | 27 / 16 | 27 / 17 | 25 / 9 | 12 / 3 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $344.23B | $326.75B | $392.68B | $328.09B | $379.97B | $355.14B | $418.95B | $349.44B |
| Low | $341.36B | $323.31B | $382.02B | $319.19B | $369.66B | $345.50B | $407.58B | $339.96B |
| High | $347.10B | $330.12B | $404.47B | $337.94B | $391.38B | $365.79B | $431.53B | $359.93B |
| EBITDA Avg | $9.35B | $8.87B | $10.66B | $8.91B | $10.32B | $9.64B | $11.38B | $9.49B |
| Low | $9.27B | $8.78B | $10.37B | $8.67B | $10.04B | $9.38B | $11.07B | $9.23B |
| High | $9.43B | $8.96B | $10.98B | $9.18B | $10.63B | $9.93B | $11.72B | $9.77B |
| EBIT Avg | $6.97B | $6.62B | $7.96B | $6.65B | $7.70B | $7.19B | $8.49B | $7.08B |
| Low | $6.92B | $6.55B | $7.74B | $6.47B | $7.49B | $7.00B | $8.26B | $6.89B |
| High | $7.03B | $6.69B | $8.19B | $6.85B | $7.93B | $7.41B | $8.74B | $7.29B |
| Net Income Avg | $7.93B | $9.71B | $7.56B | $9.29B | $11.03B | $11.68B | $11.45B | $14.72B |
| Low | $7.65B | $9.37B | $7.29B | $8.96B | $10.64B | $11.27B | $11.05B | $14.20B |
| High | $8.24B | $10.09B | $7.85B | $9.65B | $11.46B | $12.13B | $11.90B | $15.29B |
| EPS Avg | $5.54 | $6.78 | $5.28 | $6.49 | $7.70 | $8.15 | $8.00 | $10.27 |
| Low | $5.34 | $6.54 | $5.09 | $6.26 | $7.43 | $7.87 | $7.71 | $9.91 |
| High | $5.75 | $7.04 | $5.48 | $6.74 | $8.00 | $8.47 | $8.31 | $10.67 |
| Analysts (Rev / EPS) | 9 / 9 | 7 / 8 | 4 / 6 | 4 / 3 | 3 / 5 | 3 / 3 | 3 / 6 | 2 / 4 |